Strategic collaboration in Estonia progresses: Nightingale Health completes the analysis of 200,000 Estonian Biobank samples
Press release, 8 March 2023 at 1:30 p.m. (EET) Nightingale Health Plc (“Nightingale Health”), a technology company promoting preventative health with its proprietary health risk detection platform, has analyzed and delivered to Estonian Biobank the analysis results from blood samples of 200,000 Estonian Biobank participants. Nightingale Health and Estonian Biobank announced in 2021 their long-term strategic collaboration constituting an initiative to empower the population of Estonia with modern tools of personalized medicine to realize early disease prevention. The participants of